For: | Mei SW, Liu Z, Wei FZ, Chen JN, Wang ZJ, Shen HY, Li J, Zhao FQ, Pei W, Wang Z, Wang XS, Liu Q. Impact of interval between neoadjuvant chemoradiotherapy and surgery in rectal cancer patients. World J Gastroenterol 2020; 26(31): 4624-4638 [PMID: 32884221 DOI: 10.3748/wjg.v26.i31.4624] |
---|---|
URL: | https://www.wjgnet.com/1948-5204/full/v26/i31/4624.htm |
Number | Citing Articles |
1 |
Bo P Smalbroek, Teus J Weijs, Lea M Dijksman, Floris B Poelmann, Lucas Goense, Robert R Dijkstra, Niels A T Wijffels, Djamila Boerma, Anke B Smits, F J Amelung, E C J Consten, T A Burghgraef, D A Hess, R Roukema, A Demirkiran, M Tenhagen, J Straatman, G Nieuwenhuijzen, H J T Rutten, G Vugts, B Inberg, A Kreiter, S Scheurs, M F Gerhards, R L G M Blom, M J A M Russchen, A van den Berg, J W T Dekker, H P Versteegh, F W H Kloppenberg, I S Bakker, J T H Hamminga, J L M Konsten, M van Heinsbergen, S T van Vugt, J E Bouwman, J T Heikens, A van den Berg, M Takkenberg, L Graat, A J N M Bastiaansen, E A Gorter, J W S Merkus, E G Boerma, L Koolen, D Jean Pierre, E van der Harst, W Hogendoorn, L H Wijngaarden, R T J kortekaas, M C Struijs, N Heuchemer, P Fockens, E E van Halsema, W A A Borstlap, P J Tanis, J Veld, W A Bemelman, D D Wisselink, A C H M Jongen, V N E Schuermans, N D Bouvy, C S Andeweg, J W Foppen, J Heemskerk, J Scheerhoorn, P van der Sluis, N Smakman, E R J Bruns, E S van der Zaag, H J Schuiten, T Argillander, K Parry, D Lips, H Algera, P Poortman, C Steur, H A Swank, B Lamme, M N N J Arron, D van Uden, P D Siersema, J H W de Wilt, L Daniels, D J A Sonneveld, K Nielsen, I Masselink, L M Lutke Holzik, G Lo, A G Menon, J F Lange, B J van Wely, A van Esch, D E Moes, B M M Reuber, B H M Heijnen, I de Groot-van Veen, A W H van de Ven, C C M Marres, H E Haak, M Vermaas, P van Hagen, H L van Westreenen, J W A de Haas, J M Klaase, M J F van Veen, A Mearadji, J Heeren, R Silvis, J A M G Tol, C J L Molenaar, J A van Essen, T Lettinga, L Verkoele, G L Beets, D D E Zimmerman, Y T van Loon, P Oomen, H S de Vries, J E van Hooft, K C M J Peeters, N D A Boye, F ter Borg, A K Talsma, A A Wijkmans, A A W van Geloven, N van Oorschot, B Blomberg, W M U van Grevenstein, J L Tolenaar, F C den Boer, J C Sierink, T Paulides, B M M Reiber, B van de Beukel, J B Tuynman, H T Bransma, A R M Brandt-Kerkhof, M E E Bröker, R M P H Crolla, J van der Slegt, T L Janssen, C Werker, H J Schuijt, M J Wiezer, K van Dongen, V Kornmann, L Tseng, D Smit, C Sietses, T Visser, G D Algie, M J Nieboer, P A Neijenhuis, S F Durmaz, T H J Aufenacker, N Hugen, M van Basten Batenburg, M Westerterp, J van Groningen, W J de Jong, R J Renger, F Logeman, G Slooter, K Arts, J Wegdam, G Meisen, B Wiering, H C J van der Mijle, I Paulusma, M van der Sluis, K Havenga, J P M Burbach, E J B Furnee, B Polle, C Hoff, F Poelmann, T L R Zwols, T C van Sprundel, S C Veltkamp, M van de Wilt, W J Vles, A Kamman, H Schippers, R L van der Hul, A Breijer, W Kelder, B van den Hengel, R Klicks, E F Kelling, A P J Houdijk, L Heijnen, F Wit, M Dam, M Raber, D J L M de Mey, W van den Broek, L Verslijs, G W de Klein, W M J de Ruijter, R de Vos tot Nederveen Cappel. Use of ileostomy versus colostomy as a bridge to surgery in left-sided obstructive colon cancer: retrospective cohort study. BJS Open 2023; 7(3) doi: 10.1093/bjsopen/zrad038
|
2 |
Xiaojie Wang, Zhifang Zheng, Heyuan Zhu, Qian Yu, Shenghui Huang, Xingrong Lu, Ying Huang, Pan Chi. Timing to achieve the best recurrence-free survival after neoadjuvant chemoradiotherapy in locally advanced rectal cancer: experience in a large-volume center in China. International Journal of Colorectal Disease 2021; 36(5): 1007 doi: 10.1007/s00384-020-03829-y
|
3 |
Shuang Liu, Ting Jiang, Lin Xiao, Shanfei Yang, Qing Liu, Yuanhong Gao, Gong Chen, Weiwei Xiao. Total Neoadjuvant Therapy (TNT) versus Standard Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer: A Systematic Review and Meta-Analysis
. The Oncologist 2021; 26(9): e1555 doi: 10.1002/onco.13824
|
4 |
Maria Cambray, Javier González-Viguera, Ferran Losa, Mercedes Martínez-Villacampa, Ricard Frago, Fernando Mata, Jordi Castellví, Elisabet Guinó. Determining the optimal interval between neoadjuvant radiochemotherapy and surgery in rectal cancer: a retrospective cohort study. International Journal of Colorectal Disease 2023; 38(1) doi: 10.1007/s00384-023-04457-y
|
5 |
Junbing Chen, Zhouqiao Wu, Xiaoyan Zhang, Zining Liu, Yiding Wang, Fei Shan, Yinkui Wang, Shaojun Xia, Yan Zhang, Yingshi Sun, Jiafu Ji, Ziyu Li. Optimized tools and timing of response reassessment after neoadjuvant chemoradiation in rectal cancer. International Journal of Colorectal Disease 2022; 37(11): 2321 doi: 10.1007/s00384-022-04268-7
|
6 |
J. Yang, W. Wang, Y. Luo, S. Huang, Z. Fu. Effect of pathological complete response after neoadjuvant chemoradiotherapy on postoperative complications of rectal cancer: a systematic review and meta-analysis. Techniques in Coloproctology 2022; 26(3): 163 doi: 10.1007/s10151-021-02564-y
|
7 |
Matthew C. Bobel, Michael F. McGee. Determining the optimal radiation‐surgery interval (RSI) for oncologic proctectomy following radiotherapy for rectal adenocarcinoma. Journal of Surgical Oncology 2023; 127(8): 1252 doi: 10.1002/jso.27273
|
8 |
Yuhao Zhai, Zhi Zheng, Wei Deng, Jie Yin, Zhigang Bai, Xiaoye Liu, Jun Zhang, Zhongtao Zhang. Interval time between neoadjuvant chemotherapy and surgery in advanced gastric cancer doesn't affect outcome: A meta analysis. Frontiers in Surgery 2023; 9 doi: 10.3389/fsurg.2022.1047456
|
9 |
Irene Hing‐fong Cheung, Michelle Hau‐ching Lo, Michael Chi‐ming Poon. Impact of time interval between neoadjuvant chemoradiotherapy and surgery on oncological outcomes of locally advanced rectal cancer. Surgical Practice 2023; 27(1): 15 doi: 10.1111/1744-1633.12584
|
10 |
Shuang Liu, XiaoZhong Wang, YeZhong Zhuang, ShouMin Bai, XiaoJun Wu, YiJing Ye, HuiLong Luo, HaiNa Yu, QiaoXuan Wang, Hui Chang, ZhiFan Zeng, PeiQiang Cai, ZhiZhong Pan, YuanHong Gao, Gong Chen, WeiWei Xiao. Total neoadjuvant treatment to increase the clinical complete response rate for distal locally advanced rectal cancer (TESS): A study protocol of a prospective, open‐label, multicenter, single‐arm, phase 2 trial. Cancer Medicine 2023; 12(12): 13352 doi: 10.1002/cam4.6034
|
11 |
Jia-yi Li, Xuan-zhang Huang, Peng Gao, Yong-xi Song, Xiao-wan Chen, Xing-er Lv, Yv Fu, Qiong Xiao, Shi-yv Ye, Zhen-ning Wang. Survival landscape of different tumor regression grades and pathologic complete response in rectal cancer after neoadjuvant therapy based on reconstructed individual patient data. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08922-1
|
12 |
Li Chen, Wenchao Zhu, Wei Zhang, Engeng Chen, Wei Zhou. Magnetic resonance imaging radiomics-based prediction of severe inflammatory response in locally advanced rectal cancer patients after neoadjuvant radiochemotherapy. Langenbeck's Archives of Surgery 2024; 409(1) doi: 10.1007/s00423-024-03416-7
|
13 |
Antonio Costanzo, Valentina Rampulla. . Interdisciplinary Cancer Research 2024; doi: 10.1007/16833_2024_256
|